BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3804148)

  • 1. [Therapy of drug-resistant ventricular arrhythmias].
    Lessem JN; Hamby RA
    Fortschr Med; 1986 Nov; 104(41):784-6. PubMed ID: 3804148
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of acute cardiac arrhythmias using adrenergic beta blockaders. Experience with sotalol].
    Martín Jadraque L; Liste Jiménez D; González Maqueda I; Del Rio Bustos A
    Rev Esp Cardiol; 1975; 38(2):153-62. PubMed ID: 1135483
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term sotalol therapy in patients with ventricular arrhythmias.
    Mary-Rabine L; Soumagne D; Stiels B
    Acta Cardiol; 1986; 41(2):89-97. PubMed ID: 2424202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the beta-adrenoceptor-blocking agent Sotalol on ventricular arrhythmias in patients with chronic ischemic heart disease. A placebo-controlled, double-blind cross-over study.
    Burckhardt D; Pfisterer M; Hoffmann A; Burkart F; Emmenegger H; Jost M; Bolli P; Buehler FR
    Cardiology; 1983; 70 Suppl 1():114-21. PubMed ID: 6342778
    [No Abstract]   [Full Text] [Related]  

  • 5. [Brazilian multicenter study of sotalol effectiveness in ventricular arrhythmias].
    Maia IG; Lorga AM; de Paola AA; Rassi A; Perez AK; Sobral D; Atie J; Gizzi JC; Darwich R
    Arq Bras Cardiol; 1996 Mar; 66(3):173-8. PubMed ID: 8762699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mexiletine in ventricular arrhythmias--an assessment by 24 hours holter monitoring.
    Gambhir DS; Khalilullah M; Bahl VK
    Indian Heart J; 1984; 36(3):142-6. PubMed ID: 6490043
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of sotalol on heart rate variability in patients with symptomatic, complex ventricular arrhythmias].
    Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Apr; 83(4):293-8. PubMed ID: 8023542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [QT time and the ventricular refractory period in programmed electrical stimulation of the heart in patients with ventricular and supraventricular tachycardias--effect of sotalol].
    Wehr M
    Z Kardiol; 1986 Dec; 75(12):744-50. PubMed ID: 3825224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long term treatment with metoprolol and sotalol on ventricular repolarisation measured by use of transoesophageal atrial pacing.
    Blomström-Lundqvist C; Dohnal M; Hirsch I; Lindblad A; Hjalmarson A; Olsson SB; Edvardsson N
    Br Heart J; 1986 Feb; 55(2):181-6. PubMed ID: 3080012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with sotalol in the treatment of cardiac arrhythmias.
    Kirschenbaum HL; Rosenberg JM
    Clin Ther; 1994; 16(3):346-64. PubMed ID: 7923303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory management of ventricular arrhythmias.
    Morganroth J
    Med Times; 1980 Jan; 108(1):42-6. PubMed ID: 7374399
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the antiarrhythmic effects of Sotalol given orally].
    Fauchier JP; Neel C; Garabedian V; Cosnay P; Brochier M
    Ann Cardiol Angeiol (Paris); 1982 Jun; 31(4):329-38. PubMed ID: 7137863
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term drug therapy of arrhythmias (with special reference to ventricular tachyarrhythmias].
    Gertsch M
    Schweiz Med Wochenschr; 1984 Jan; 114(3):77-86. PubMed ID: 6199838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between ventricular function and antiarrhythmic responses to sotalol.
    Singh SN; Chen YW; Cohen A; Obeid M; Tracy C; Woosley RL; Fletcher RD
    Am J Cardiol; 1989 Oct; 64(14):943-5. PubMed ID: 2801566
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
    Bluschke V; Breithardt G; Abendroth RR; Seipel L
    Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sotalol--pharmacology, effect on hemodynamics and interactions].
    Nyznyk M; Walczak F; Jodkowska-Skarzyńska M; Kulicka D
    Pol Tyg Lek; 1993 Apr 5-12; 48(14-15):321-3. PubMed ID: 8415246
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of a new anti-arrhythmic drug, bunaftine, on intra-atrial, atrio-ventricular and intraventricular conduction of the stimulus].
    Grazi S; Romano S; Bonazzi O; Pozzoni L; Cavoretto D; Gardumi M; Sardella F
    Cardiol Prat; 1974; 25(3):213-8. PubMed ID: 4434374
    [No Abstract]   [Full Text] [Related]  

  • 18. Sotalol marketed for life-threatening arrhythmias.
    Clin Pharm; 1993 Mar; 12(3):176. PubMed ID: 8491074
    [No Abstract]   [Full Text] [Related]  

  • 19. [Beta-adrenergic blockade with INPEA in arrhythmia].
    Cárdenas M; Nadal B; Sanz G
    Arch Inst Cardiol Mex; 1971; 41(1):74-85. PubMed ID: 4942627
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sotalol].
    Hohnloser SH
    Internist (Berl); 1995 Feb; 36(2):170-3; discussion 174. PubMed ID: 7737808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.